Pulmonary Arterial Hypertension - Medicaid

Prior Authorization, Quantity Limit

QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021

QP65R1-21 Update: Minnesota Health Care Programs Providers use of the Interactive Care Reviewer

QP69-21 Update for New to Market Medical Drugs: Ciltacabtagene Autoleucel

Elmiron - Commercial

Prior Authorization

Combination NSAID - Medicaid

Prior Authorization, Quantity Limit

Antiemetic Agents - Medicaid

Quantity Limit

Northera (droxidopa) - Commercial

Prior Authorization, Quantity Limit

Jynarque - Medicaid

Prior Authorization, Quantity Limit

Jynarque - Commercial

Prior Authorization, Quantity Limit